SCHEMBL30148544

SCHEMBL30148544

OCC(F)(F)c1ccccc1F

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.40
KCNE1 P15382 1/20 0.36
KCNQ1 P51787 1/20 0.36
PDK2 Q15119 3/20 0.33
ALDH1A1 P00352 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
KIF11 P52732 1/20 0.33
PDK1 Q15118 1/20 0.33
PDK3 Q15120 1/20 0.33
PDK4 Q16654 1/20 0.33
PTGS2 P35354 1/20 0.33
CTNNB1 P35222 1/20 0.33
WNT3A P56704 1/20 0.33
SLC22A12 Q96S37 1/20 0.33
TAAR1 Q96RJ0 1/20 0.32
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9277677 1.00 KCNN4 (0.40) KCNN4KCNE1KCNQ1PDK2ALDH1A1
SCHEMBL28994163 0.83 KCNN4 (0.38) KCNN4KCNE1KCNQ1PDK2ALDH1A1
SCHEMBL9451586 0.79 KCNN4 (0.41) KCNN4KCNE1KCNQ1ALDH1A1CES2
SCHEMBL17398578 0.77 APOBEC3G (0.41) PDK2ALDH1A1
SCHEMBL27321412 0.77 ACHE (0.37) KCNN4KCNE1KCNQ1KIF11SLC22A12
SCHEMBL9277822 0.77 TAAR1 (0.41) KCNN4KCNE1KCNQ1ALDH1A1KIF11
SCHEMBL9278300 0.76 KCNN4 (0.41) KCNN4PDK2ALDH1A1KIF11PDK1
SCHEMBL2139453 0.76 KCNN4 (0.39) KCNN4KCNE1KCNQ1PDK2ALDH1A1
SCHEMBL30360667 0.76 CA1 (0.46) PDK2ALDH1A1PDK1PDK3PDK4
SCHEMBL15314792 0.76 ACHE (0.38) PDK2ALDH1A1KIF11PDK1PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268209-A1 DERIVATIVE HAVING PYRIMIDINE-FUSED CYCLIC STRUCTURE, AND USE THEREOF 四川汇宇制药股份有限公司 2022-12-29 WO disclosed
WO-2022262691-A1 HETEROCYCLIC COMPOUNDS AS SOS1 INHIBITORS BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) 2022-12-22 WO disclosed